Accelrys Inc. announce that Pfizer Inc. has signed a three-year contract with Accelrys, extending the companies' long-standing strategic partnership. The agreement continues the global deployment of the Accelrys Enterprise Platform, Pipeline Pilot, Cheminformatics Suite and Modeling & Simulation software to Pfizer researchers worldwide. The scientifically aware Accelrys Enterprise Platform offers access to broad scientific informatics solutions across different domains while simplifying integration into existing IT environments. The Pipeline Pilot scientific workflow authoring application enables scientific services that automate the process of accessing, analyzing and reporting scientific data for sharing across the scientific community. Leveraging the Accelrys Cheminformatics Suite, scientists can register, search, mine, analyze and report on chemical structures and reactions, chemically modified sequences and associated information such as inventory, assay and analytical results. Accelrys Modeling and Simulation software accelerates collaborative research and development of innovative health care treatments through the use of predictive science.

Accelrys Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the reported total revenue of $42,138,000 against $39,439,000 a year ago. Operating loss was $6,462,000 against $3,188,000 a year ago. Loss before taxes was $4,989,000 against $1,557,000 a year ago. Net loss was $5,726,000 against $2,254,000 a year ago. Basic and diluted net loss per share was $0.10 against $0.04 a year ago. Non-GAAP revenue was $43,906,000 against $41,796,000 a year ago. Non-GAAP operating income was $4,405,000 against $5,552,000 a year ago. Capital expenditure was $2,253,000 against $771,000 a year ago. The increase was primarily attributable to its completion of an Oracle R12 upgrade and the construction of its new corporate headquarters in San Diego. Non-GAAP free cash flow was $4,442,000 against $7,711,000 a year ago. Non-GAAP net income was $3,554,000 against $4,612,000 a year ago. Non-GAAP diluted net income per share was $0.06 against $0.08 a year ago. Adjusted EBITDA was $6.7 million or 15.2% of non-GAAP revenue compared to $8.1 million or 19.4% of non-GAAP revenue for first quarter of calendar 2012. For the year ending December 31, 2013, the company expects non-GAAP revenue to be between $176 and $181 million, and non-GAAP diluted earnings per share to be between $0.32 and $0.34 per diluted share on fully diluted weighted average shares outstanding of 57.0 million and using an effective tax rate of 40%.

Accelrys Inc., Q1 2013 Earnings Call, Apr 30, 2013